Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non‐resectable hepatocellular carcinoma tumours of ≥3 cm-Reference-Cited by-同舟云学术

Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non‐resectable hepatocellular carcinoma tumours of ≥3 cm

Published:2015-02 Issue:2 Volume:17 Page:140-149
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Jacob Rojymon,Turley Falynn,Redden David T.,Saddekni Souheil,Aal Ahmed K.A.,Keene Kimberly,Yang Eddy,Zarzour Jessica,Bolus David,Smith J. Kevin,Gray Stephen,White Jared,Eckhoff Devin E.,DuBay Derek A.

Funder

NIH NIDDK

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

2. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

3. Current strategy for staging and treatment: the BCLC update and future prospects;Forner;Semin Liver Dis,2010

4. Prognosis of hepatocellular carcinoma: the BCLC staging classification;Llovet;Semin Liver Dis,1999

5. National Comprehensive cancer Network guidelines for hepatobiliary cancers;National Comprehensive Cancer Network,2013

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy;Strahlentherapie und Onkologie;2024-04-30

2. Hepatobiliary Malignancies;Hypofractionated and Stereotactic Radiation Therapy;2024

3. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma;Journal of Liver Cancer;2023-03-31

4. Start Combining, Stop Comparing;International Journal of Radiation Oncology*Biology*Physics;2023-02

5. Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II Study;Technology in Cancer Research & Treatment;2023-01